Zhubei City, Taiwan · Founded 2022 · Privately Held (backing)
Developer and provider of liquid biopsy tests intended for the early detection of cancer. Pharus Diagnostics is based in Zhubei City, Taiwan and was founded in 2022. Its last reported valuation was $43 million in Apr 2025. It has raised $17.1 million.
Last reported valuation
$43.0M
Oct 2026
Priced at
—
Total raised
$17.1M
Last round
—
Cap table — not yet on record
Pharus Diagnostics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Pharus Diagnostics with a free account
·Watch Pharus Diagnostics: the Monday email on marks, rounds and moves
